{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:52:50Z","timestamp":1715986370854},"reference-count":57,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.clinthera.2010.06.021","type":"journal-article","created":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T08:59:22Z","timestamp":1280998762000},"page":"1270-1284","source":"Crossref","is-referenced-by-count":8,"title":["Effectiveness of barnidipine 10 or 20 mg plus losartan 50-mg combination versus losartan 100-mg monotherapy in patients with essential hypertension not controlled by losartan 50-mg monotherapy: A 12-week, multicenter, randomized, open-label, parallel-group study"],"prefix":"10.1016","volume":"32","clinical-trial-number":[{"clinical-trial-number":"2006-001469-41","registry":"10.18810\/euctr"}],"author":[{"given":"Gianfranco","family":"Parati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Lonati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Destro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra Rossi","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Cagnoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Pini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achille","family":"Venco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Maria","family":"Maresca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Monza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Grandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Omboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2010.06.021_bib1","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bmj.39548.738368.BE","article-title":"Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: Metaanalysis of randomised trials","volume":"336","author":"Turnbull","year":"2008","journal-title":"BMJ."},{"key":"10.1016\/j.clinthera.2010.06.021_bib2","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ."},{"key":"10.1016\/j.clinthera.2010.06.021_bib3","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","article-title":"Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document","volume":"27","author":"Mancia","year":"2009","journal-title":"J Hypertens."},{"key":"10.1016\/j.clinthera.2010.06.021_bib4","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII report) [published correction appears in JAMA. 2003;290:197]","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA."},{"key":"10.1016\/j.clinthera.2010.06.021_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet."},{"key":"10.1016\/j.clinthera.2010.06.021_bib6","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet."},{"key":"10.1016\/j.clinthera.2010.06.021_bib7","first-page":"703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 [published correction appears in BMJ. 1999; 318:29]","volume":"317","year":"1998","journal-title":"BMJ."},{"key":"10.1016\/j.clinthera.2010.06.021_bib8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","article-title":"Morbidity and mortality in patients randomised to doubleblind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) [published correction appears in Lancet. 2000;356:514]","volume":"356","author":"Brown","year":"2000","journal-title":"Lancet."},{"key":"10.1016\/j.clinthera.2010.06.021_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(00)02526-5","article-title":"Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study","volume":"356","author":"Hansson","year":"2000","journal-title":"Lancet."},{"key":"10.1016\/j.clinthera.2010.06.021_bib10","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","article-title":"The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in moderately hypercho-lesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)","volume":"288","year":"2002","journal-title":"JAMA."},{"key":"10.1016\/j.clinthera.2010.06.021_bib11","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet."},{"key":"10.1016\/j.clinthera.2010.06.021_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMoa021716","article-title":"A comparison of outcomes with angiotensin-converting\u2014enzyme inhibitors and diuretics for hypertension in the elderly","volume":"348","author":"Wing","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2010.06.021_bib13","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/jama.289.16.2073","article-title":"Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial","volume":"289","author":"Black","year":"2003","journal-title":"JAMA."},{"key":"10.1016\/j.clinthera.2010.06.021_bib14","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet."},{"key":"10.1016\/j.clinthera.2010.06.021_bib15","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med."},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2010.06.021_bib16","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1038\/sj.jhh.1001435","article-title":"Combination therapy with AT(1)-receptor blockers","volume":"16","author":"Trenkwalder","year":"2002","journal-title":"J Hum Hypertens."},{"key":"10.1016\/j.clinthera.2010.06.021_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1527-3466.2005.tb00159.x","article-title":"Saga of renin-angiotensin system and calcium channels in hypertensive diabetics: Does it have a therapeutic edge?","volume":"23","author":"Kumar","year":"2005","journal-title":"Cardiovasc Drug Rev."},{"key":"10.1016\/j.clinthera.2010.06.021_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1586\/14779072.3.2.207","article-title":"Barnidipine: A new calcium channel blocker for hypertension treatment","volume":"3","author":"Liau","year":"2005","journal-title":"Expert Rev Cardiovasc Ther."},{"key":"10.1016\/j.clinthera.2010.06.021_bib19_1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003495-200161070-00007","article-title":"Barnidipine","volume":"61","author":"Malhotra","year":"2001","journal-title":"Drugs."},{"key":"10.1016\/j.clinthera.2010.06.021_bib19_2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2165\/00003495-200161070-00007","article-title":"Barnidipine","volume":"61","author":"Malhotra","year":"2001","journal-title":"Drugs."},{"key":"10.1016\/j.clinthera.2010.06.021_bib20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1023\/A:1007778706354","article-title":"Barnidipine, a novel calcium antagonist for once-daily treatment of hypertension: A multicenter, double-blind, placebo-controlled, dose-ranging study","volume":"11","author":"Hart","year":"1997","journal-title":"Cardiovasc Drugs Ther."},{"key":"10.1016\/j.clinthera.2010.06.021_bib21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.5414\/CPP38304","article-title":"Natriuretic effect of barnidipine, a longacting dihydropyridine calcium channel blocker, in patients with essential hypertension","volume":"38","author":"Ohya","year":"2000","journal-title":"Int J Clin Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2010.06.021_bib22","first-page":"27","article-title":"Barnidipine monotherapy and combination therapy in older patients with essential hypertension: A longterm study","author":"Naber","year":"2000","journal-title":"Int J Clin Pract Suppl."},{"key":"10.1016\/j.clinthera.2010.06.021_bib23","first-page":"20","article-title":"The long-term efficacy and safety profile of barnidipine","author":"Smilde","year":"2000","journal-title":"Int J Clin Pract Suppl."},{"key":"10.1016\/j.clinthera.2010.06.021_bib24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/147323000603400410","article-title":"Comparative study of barnidipine and felodipine in Chinese patients with essential hypertension","volume":"34","author":"Zhu","year":"2006","journal-title":"J Int Med Res."},{"key":"10.1016\/j.clinthera.2010.06.021_bib25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/147323000203000317","article-title":"Efficacy and safety of barnidipine compared with felodipine in the treatment of hypertension in Chinese patients","volume":"30","author":"Liau","year":"2002","journal-title":"J Int Med Res."},{"key":"10.1016\/j.clinthera.2010.06.021_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/080370598438555","article-title":"Efficacy and tolerability of once-daily barnidipine in the clinical management of patients with mild to moderate essential hypertension","volume":"1","author":"Spieker","year":"1998","journal-title":"Blood Press Suppl."},{"key":"10.1016\/j.clinthera.2010.06.021_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/080370598438564","article-title":"The role of combination therapy in the treatment of hypertension","volume":"1","author":"Ruilope","year":"1998","journal-title":"Blood Press Suppl."},{"key":"10.1016\/j.clinthera.2010.06.021_bib28","first-page":"10","article-title":"Treatment of hypertension in the very old","author":"Otterstad","year":"2000","journal-title":"Int J Clin Pract Suppl."},{"key":"10.1016\/j.clinthera.2010.06.021_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/147323000403200212","article-title":"The efficacy and tolerability of barnidipine hydrochloride in Thai patients with hypertension","volume":"32","author":"Buranakitjaroen","year":"2004","journal-title":"J Int Med Res."},{"key":"10.1016\/j.clinthera.2010.06.021_bib30","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0895-7061(97)00361-0","article-title":"Evaluation of the antihypertensive effect of barnidipine, a dihydropyridine calcium entry blocker, as determined by the ambulatory blood pressure level averaged for 24 h, daytime, and nighttime","volume":"10","author":"Imai","year":"1997","journal-title":"Am J Hypertens."},{"key":"10.1016\/j.clinthera.2010.06.021_bib31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.curtheres.2008.06.002","article-title":"Antihypertensive effect of barnidipine 10 mg or amlodipine 5 to 10 mg once daily in treatment-naive patients with essential hyperten sion: A 24-week, randomized, openlabel, pilot study","volume":"69","author":"Rossetti","year":"2008","journal-title":"Curr Ther Res Clin Exp."},{"key":"10.1016\/j.clinthera.2010.06.021_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.curtheres.2008.06.003","article-title":"Effects of barnidipine on blood pressure and left ventricular diastolic function in patients with hypertension and metabolic syndrome: A 12-week, open-label non-comparison study","volume":"69","author":"Angeli","year":"2008","journal-title":"Curr Ther Res Clin Exp."},{"key":"10.1016\/j.clinthera.2010.06.021_bib33","first-page":"26","article-title":"Prescrizione e condizioni di carattere generale, relative all\u2019esecuzione delle sperimentazioni cliniche dei medicinali, con particolare riferimento a quelle ai fini del miglioramento della pratica clinica, quale parte integrante dell\u2019assistenza sanitaria (DM 17\/12\/2004)","volume":"43","year":"2005","journal-title":"Gazzetta Ufficiale della Repubblica Italiana"},{"key":"10.1016\/j.clinthera.2010.06.021_bib34","first-page":"34","article-title":"Directive 2001\/20\/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use","volume":"44","year":"2001","journal-title":"Official Journal of the European Communities"},{"key":"10.1016\/j.clinthera.2010.06.021_bib35","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2165\/00003495-199651050-00008","article-title":"Losartan potassium: A review of its pharmacology, clinical efficacy and tolerability in the management of hypertension [published correction appears in Drugs. 1996;52:540]","volume":"51","author":"Goa","year":"1996","journal-title":"Drugs."},{"key":"10.1016\/j.clinthera.2010.06.021_bib36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00126097-200008000-00006","article-title":"Validation of A&D UA-767 device for the self-measurement of blood pressure","volume":"5","author":"Rogoza","year":"2000","journal-title":"Blood Press Monit."},{"key":"10.1016\/j.clinthera.2010.06.021_bib37","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/01.hjh.0000163132.84890.c4","article-title":"Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement","volume":"23","author":"O\u2019Brien","year":"2005","journal-title":"J Hyper- tens."},{"key":"10.1016\/j.clinthera.2010.06.021_bib38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/01.CIR.0000154900.76284.F6","article-title":"Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Blood pressure measurement in humans: A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research","volume":"111","author":"Pickering","year":"2005","journal-title":"Circulation."},{"key":"10.1016\/j.clinthera.2010.06.021_bib39","first-page":"S11","article-title":"Twenty-fourhour ambulatory blood pressure monitoring: A review of validation data","volume":"8","author":"O\u2019Brien","year":"1990","journal-title":"J Hypertens Suppl."},{"key":"10.1016\/j.clinthera.2010.06.021_bib40","first-page":"255","article-title":"Validation of the A&D TM-2430 device for ambulatory blood pressure monitoring and evaluation of performance according to subjects' characteristics","volume":"3","author":"Palatini","year":"1998","journal-title":"Blood Press Monit."},{"key":"10.1016\/j.clinthera.2010.06.021_bib41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/0151642-200815040-00008","article-title":"Italian Society of Hypertension Guidelines for Conventional and Automated Blood Pressure Measurement in the Office, at Home and Over 24 Hours","volume":"15","author":"Parati","year":"2008","journal-title":"High Blood Pressure & Cardiovascular Prevention."},{"key":"10.1016\/j.clinthera.2010.06.021_bib42","first-page":"110","article-title":"Beyond trough:peak ratio: A new index of the smoothness of the antihypertensive effect of a drug","volume":"6","author":"Rizzoni","year":"1997","journal-title":"High Blood Press."},{"key":"10.1016\/j.clinthera.2010.06.021_bib43","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/00004872-199816110-00016","article-title":"The smoothness index: A new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension","volume":"16","author":"Parati","year":"1998","journal-title":"J Hypertens."},{"key":"10.1016\/j.clinthera.2010.06.021_bib44","first-page":"201","article-title":"The trough:peak ratio and the smoothness index in the evaluation of control of 24 h blood pressure by treatment in hypertension","volume":"3","author":"Omboni","year":"1998","journal-title":"Blood Pressure Monit."},{"key":"10.1016\/j.clinthera.2010.06.021_bib45","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00004872-200104000-00007","article-title":"The smoothness index, but not the trough-to-peak ratio predicts changes in carotid artery wall thickness during antihypertensive treatment","volume":"19","author":"Rizzoni","year":"2001","journal-title":"J Hypertens."},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2010.06.021_bib46","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1097\/00004872-200406002-00998","article-title":"Morning blood pressure surge and left ventricular mass in treated hypertensive patients","volume":"22","author":"Bilo","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.clinthera.2010.06.021_bib47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MBP.0b013e3282fd16a9","article-title":"Prognostic significance of morning surge in blood pressure: Which definition, which outcome?","volume":"13","author":"Ohkubo","year":"2008","journal-title":"Blood Press Monit."},{"key":"10.1016\/j.clinthera.2010.06.021_bib48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00126097-200202000-00013","article-title":"Japanese Multicentre Study on Barnidipine with Ambulatory Blood Pressure Monitoring. Effects of the long-acting calcium channel blocker barnidipine hydro-chloride on 24-h ambulatory blood pressure","volume":"7","author":"Kuwajima","year":"2002","journal-title":"Blood Press Monit."},{"key":"10.1016\/j.clinthera.2010.06.021_bib49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00129784-200505010-00006","article-title":"Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: A comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan [published correction appears in Am J Cardiovasc Drugs. 2005;5:209]","volume":"5","author":"Smith","year":"2005","journal-title":"Am J Cardiovasc Drugs."},{"key":"10.1016\/j.clinthera.2010.06.021_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00004872-199102000-00003","article-title":"Reproducibility of non-invasive and intra-arterial blood pressure monitoring: Implications for studies on antihypertensive treatment","volume":"9","author":"Trazzi","year":"1991","journal-title":"J Hypertens."},{"key":"10.1016\/j.clinthera.2010.06.021_bib51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0895-7061(94)00250-F","article-title":"Lack of placebo effect on ambulatory blood pressure","volume":"8","author":"Mancia","year":"1995","journal-title":"Am J Hypertens."},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2010.06.021_bib52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00148475","article-title":"Ambulatory pressure monitoring in the assessment of antihypertensive therapy","volume":"3","author":"Coats","year":"1989","journal-title":"Cardiovasc Drugs Ther."},{"key":"10.1016\/j.clinthera.2010.06.021_bib53","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1097\/01.hjh.0000251894.17132.54","article-title":"Prevalence of the white-coat effect at multiple visits before and during treatment","volume":"24","author":"Verberk","year":"2006","journal-title":"J Hypertens."},{"key":"10.1016\/j.clinthera.2010.06.021_bib54","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00126097-200110000-00006","article-title":"How should we measure blood pressure in the doctor's office?","volume":"6","author":"Gerin","year":"2001","journal-title":"Blood Press Monit."},{"key":"10.1016\/j.clinthera.2010.06.021_bib55_1","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","article-title":"Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice","volume":"21","author":"Farmer","year":"1999","journal-title":"Clin Ther."},{"key":"10.1016\/j.clinthera.2010.06.021_bib55_2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0149-2918(99)80026-5","article-title":"Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice","volume":"21","author":"Farmer","year":"1999","journal-title":"Clin Ther."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810002262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810002262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T10:00:47Z","timestamp":1559383247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291810002262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0149291810002262"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2010.06.021","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}